GlassScriptPhysician profile
Kendra Wilson
NPI 1992365019
$4,185.77
in general payments reported to CMS, 2019-2025
21 companies · $1,337 in 2025
The $1,337 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $365 · 2022: $461 · 2023: $1,588 · 2024: $435 · 2025: $1,337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,135 · Food and Beverage: $1,225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,135.00 |
| Food and Beverage | $1,225.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,538.54 | 2021-2025 | Collagenase Santyl, Renasys Go V2 Home, Allevyn Life L 15.4x15.4 Ctn10 |
| Paratek Pharmaceuticals, INC. | $573.70 | 2022-2025 | Nuzyra |
| Acera Surgical, INC. | $220.63 | 2021-2022 | |
| Kci USA, INC. | $134.93 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $124.80 | 2024 | Rexulti |
| Organogenesis INC. | $85.32 | 2021 | |
| Integra Lifesciences Corporation | $82.38 | 2023-2025 | Tcc-Ez |
| Reapplix INC. | $62.52 | 2023 | 3c Patch Kit - Box |
| Solventum Corporation | $57.55 | 2024-2025 | Activ.A.C. |
| Kerecis Limited | $56.98 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Abbvie INC. | $55.28 | 2023-2024 | |
| Misonix INC | $32.28 | 2021 | |
| Aroa Biosurgery Incorporated | $27.51 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.43 | 2022 | |
| Abbott Laboratories | $23.25 | 2025 | Cardiomems |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $16.48 | 2024 | |
| Cashflow Solutions, LLC | $16.19 | 2025 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
| Melinta Therapeutics, LLC | $14.85 | 2025 | Rezzayo, Orbactiv, Kimyrsa |
| Apria Healthcare LLC | $13.82 | 2021 | |
| Nestle Healthcare Nutrition INC. | $13.59 | 2021 | |
| Genentech USA, INC. | $10.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendra Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.